NRIX Competitors & Alternatives
Compare Nurix Therapeutics Inc with similar stocks in the same industry
Biotechnology
NRIX
Main Stock$24.74
Tradestie Score
63
Market Cap
$718.62M
Revenue Growth
-0.7%
Analyst Upside
+27.1%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$63.95
|
$2.42B | - | 60 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$155.46
|
$2.41B | - | 61 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$37.21
|
$2.40B | - | 55 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$26.30
|
$2.37B | - | 63 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$132.66
|
$2.35B | - | 59 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$8.80
|
$2.34B | - | 60 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$74.40
|
$2.33B | - | 63 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$37.87
|
$2.33B | - | 56 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
More NRIX Analysis
Data updated: Jun 30, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry